Results 101 to 110 of about 20,043 (161)

Human immunodeficiency virus and antiretroviral therapies exert distinct influences across diverse gut microbiomes. [PDF]

open access: yesNat Microbiol
Jabbar KS   +17 more
europepmc   +1 more source

Transcription start site heterogeneity controls MDA5 sensing of unspliced HIV-1 RNAs. [PDF]

open access: yesProc Natl Acad Sci U S A
Hughes IK   +9 more
europepmc   +1 more source

Development of Physiologically Based Pharmacokinetic (PBPK) Modeling. [PDF]

open access: yesPharmaceutics
Sánchez-Dengra B, González-Álvarez I.
europepmc   +1 more source

Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation. [PDF]

open access: yesInfect Dis (Lond)
Zheng A   +10 more
europepmc   +1 more source

Efavirenz-Altered Gut-Microbiota, <i>Tph1</i>, and Systemic 5-HT Levels: Could They Affect Depression Mechanisms in Mice? [PDF]

open access: yesInt J Mol Sci
Rojas-Osornio SA   +15 more
europepmc   +1 more source

Synthesis, in vitro anti-HIV-1 reverse transcriptase evaluation, molecular modelling, DFT analysis and acute oral toxicity assessment of benzotriazole derivatives. [PDF]

open access: yesSci Rep
Maiti NJ   +14 more
europepmc   +1 more source

Incident hypertension among adults on ART in Malawi: a nested cohort study. [PDF]

open access: yesBMC Infect Dis
Nyirenda OM   +12 more
europepmc   +1 more source

CYP2B6 polymorphisms and suicidal behaviour in people living with HIV treated with efavirenz-containing combination antiretroviral therapy: a global case-control study. [PDF]

open access: yesFront Pharmacol
Arenas-Pinto A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy